Led by Christina Reh, MD, the TrialNet team at UCLA is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, UCLA is regionally overseen by University of California - San Fransisco. If you reach out to TrialNet, you may be contacted by staff from either institution. 

University of California, San Francisco (UCSF) is one of seventeen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Stephen Gitelman, MD, the TrialNet team at UCSF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Principal Investigator, Lou Philipson, MD, the TrialNet team at the University of Chicago is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Chicago is regionally overseen by Indiana University - Riley Hospital. If you reach out to TrialNet, you may be contacted by staff from either institution. 

The University of Florida (UF) is one of seventeen Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Michael Haller, MD, the TrialNet team at UF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Valeria Benavides, the TrialNet team at University of Illinois College of Medicine at Peoria is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Illinois College of Medicine at Peoria is regionally overseen by Indiana University- Riley Hospital for Children. If you reach out to TrialNet, you may be contacted by staff from either institution. 

The University of Miami is one of seventeen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by David Baidal, MD, the TrialNet team at University of Miami is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Led by Inas Thomas, MD, the TrialNet team at University of Michigan is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Michigan is regionally overseen by Indiana University - Riley Hospital for Children. If you reach out to TrialNet, you may be contacted by staff from either institution. 

University of Minnesota is one of seventeen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Antoinette Moran, MD, the TrialNet team at University of Minnesota is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. 

Led by Kenneth Izuora, MD, the TrialNet team at the University of Nevada Las Vegas School of Medicine is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, University of Nevada Las Vegas School of Medicine is regionally overseen by Barbara Davis Center. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Nina Jain, MD, the TrialNet team at UNC Chapel Hill is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, UNC Chapel Hill is regionally overseen by Vanderbilt Eskind Diabetes Clinic. If you reach out to TrialNet, you may be contacted by staff from either institution.